Skip to main content
RAPS Convergence 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Invitation Only
Invitation Only
Separate Ticket or Advanced Registration Required
Separate Ticket or Advanced Registration Required
Repeat Solutions Circle
Repeat Solutions Circle

Junyang Wang

Director Global Regulatory Policy and Science
EMD Serono

Junyang Wang, MSc has over 15 years of public health experience and over a decade of combined regulatory policy and stakeholder engagement experiences across drugs, devices, and digital. He currently serves as Director for US Global Regulatory and Scientific Policy (GRASP) at EMD Serono and leads company-wide regulatory policy efforts within clinical trial diversity, digital health, and artificial intelligence. Prior to joining EMD Serono, he worked at the U.S. Food and Drug Administration (FDA) for over seven years leading digital health innovation, policy and guidance writing within the Digital Health Center of Excellence in the Center for Devices and Radiological Health (CDRH) as well as clinical trial policy and stakeholder engagement in the Center for Drug Evaluation and Research (CDER). His breadth of work has spanned innovating new regulatory paradigms for digital health, understanding biologic variability to drug response, and fostering transparency and meaningful engagement at FDA. He has led several efforts including Risk Determination of Software as a Medical Device (SaMD) under the Pre-Certification pilot program and spearheaded the Drug Trials Snapshots transparency initiative to name a few.
He completed his Masters of Science in Global Health as well as a Bachelors of Science in Psychology from Duke University.
In his free time, he enjoys exploring nature, culinary experimentation, and traveling to learn about the human experience across cultures.

Presentation(s):